Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Director departure
Appointed director
|
|
GENOMIC HEALTH INC (GHDX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/12/2020 |
SC 13G/A
| RENAISSANCE TECHNOLOGIES LLC reports a 0% stake in GENOMIC HEALTH, INC. |
| 11/18/2019 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 11/18/2019 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 11/18/2019 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 11/14/2019 |
4
| FUCHS HENRY J (Director) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Disposed/sold 6,878 shares
@ $0
Disposed/sold 955 shares
@ $0
Disposed/sold 10,000 options to buy
@ $26.01, valued at
$260.1k
Disposed/sold 10,000 options to buy
@ $26.18, valued at
$261.8k
Disposed/sold 10,000 options to buy
@ $31.53, valued at
$315.3k
Disposed/sold 10,000 options to buy
@ $51.72, valued at
$517.2k
Disposed/sold 6,583 options to buy
@ $52.41, valued at
$345k
|
|
| 11/14/2019 |
4
| Parker Geoffrey M. (Director) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Granted 955 shares
@ $0
Disposed/sold 20,000 options to buy
@ $26.07, valued at
$521.4k
Disposed/sold 10,000 options to buy
@ $31.53, valued at
$315.3k
Disposed/sold 10,000 options to buy
@ $51.72, valued at
$517.2k
Disposed/sold 6,583 options to buy
@ $52.41, valued at
$345k
|
|
| 11/14/2019 |
4
| Cohen Fred E (Director) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Disposed/sold 68,165 shares
@ $0
Disposed/sold 955 shares
@ $0
Disposed/sold 6,068 shares
@ $0
Disposed/sold 8,250 options to buy
@ $35.87, valued at
$295.9k
Disposed/sold 1,515 options to buy
@ $36.04, valued at
$54.6k
Disposed/sold 10,000 options to buy
@ $26.18, valued at
$261.8k
Disposed/sold 10,000 options to buy
@ $31.53, valued at
$315.3k
Disposed/sold 10,000 options to buy
@ $51.72, valued at
$517.2k
Disposed/sold 6,583 options to buy
@ $52.41, valued at
$345k
|
|
| 11/14/2019 |
4
| Flannelly Barry P (Director) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Disposed/sold 397 shares
@ $0
Disposed/sold 20,000 options to buy
@ $65.2, valued at
$1.3M
|
|
| 11/14/2019 |
4
| GRAHAM GINGER L (Director) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Disposed/sold 52,349 shares
@ $0
Disposed/sold 955 shares
@ $0
Disposed/sold 8,250 options to buy
@ $34.44, valued at
$284.1k
Disposed/sold 8,250 options to buy
@ $35.87, valued at
$295.9k
Disposed/sold 1,515 options to buy
@ $36.04, valued at
$54.6k
Disposed/sold 10,000 options to buy
@ $27.75, valued at
$277.5k
Disposed/sold 10,000 options to buy
@ $26.01, valued at
$260.1k
Disposed/sold 10,000 options to buy
@ $26.18, valued at
$261.8k
Disposed/sold 10,000 options to buy
@ $31.53, valued at
$315.3k
Disposed/sold 10,000 options to buy
@ $51.72, valued at
$517.2k
Disposed/sold 6,583 options to buy
@ $52.41, valued at
$345k
|
|
| 11/14/2019 |
4
| Leber Laura (Chief Communication Officer) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Disposed/sold 4,352 shares
@ $0
Disposed/sold 9,384 shares
@ $0
Disposed/sold 15,000 options to buy
@ $29.34, valued at
$440.1k
Disposed/sold 11,250 options to buy
@ $28.05, valued at
$315.6k
Disposed/sold 10,220 options to buy
@ $30.84, valued at
$315.2k
Disposed/sold 9,000 options to buy
@ $31.12, valued at
$280.1k
Disposed/sold 11,458 options to buy
@ $27, valued at
$309.4k
Disposed/sold 1,042 options to buy
@ $27, valued at
$28.1k
Disposed/sold 8,366 options to buy
@ $27.48, valued at
$229.9k
Disposed/sold 3,804 options to buy
@ $27.48, valued at
$104.5k
Disposed/sold 6,190 options to buy
@ $33.21, valued at
$205.6k
|
|
| 11/14/2019 |
4
| McEachron Kim (Chief People Officer) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Disposed/sold 25,293 shares
@ $0
Disposed/sold 11,261 shares
@ $0
Disposed/sold 6,562 options to buy
@ $28.05, valued at
$184.1k
Disposed/sold 10,040 options to buy
@ $30.84, valued at
$309.6k
Disposed/sold 9,000 options to buy
@ $31.12, valued at
$280.1k
Disposed/sold 13,484 options to buy
@ $27, valued at
$364.1k
Disposed/sold 1,226 options to buy
@ $27, valued at
$33.1k
Disposed/sold 9,838 options to buy
@ $27.48, valued at
$270.3k
Disposed/sold 4,472 options to buy
@ $27.48, valued at
$122.9k
Disposed/sold 7,621 options to buy
@ $33.21, valued at
$253.1k
Disposed/sold 9,799 options to buy
@ $33.21, valued at
$325.4k
|
|
| 11/14/2019 |
4
| Hoof Torsten (Chief Int'l Commercial Officer) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Disposed/sold 4,479 shares
@ $0
Disposed/sold 10,388 shares
@ $0
Disposed/sold 5,750 options to buy
@ $31.78, valued at
$182.7k
Disposed/sold 11,500 options to buy
@ $31.78, valued at
$365.5k
Disposed/sold 1,980 options to buy
@ $33.21, valued at
$65.8k
Disposed/sold 5,940 options to buy
@ $33.21, valued at
$197.3k
Disposed/sold 10,950 options to buy
@ $72.52, valued at
$794.1k
|
|
| 11/14/2019 |
4
| Radford Jason W. (Chief Legal Officer) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Disposed/sold 8,384 shares
@ $0
Disposed/sold 20,924 shares
@ $0
Disposed/sold 12,000 options to buy
@ $27.85, valued at
$334.2k
Disposed/sold 9,643 options to buy
@ $27, valued at
$260.4k
Disposed/sold 877 options to buy
@ $27, valued at
$23.7k
Disposed/sold 18,095 options to buy
@ $27.48, valued at
$497.3k
Disposed/sold 8,225 options to buy
@ $27.48, valued at
$226k
Disposed/sold 15,155 options to buy
@ $33.21, valued at
$503.3k
Disposed/sold 19,485 options to buy
@ $33.21, valued at
$647.1k
Disposed/sold 16,270 options to buy
@ $72.52, valued at
$1.2M
|
|
| 11/14/2019 |
4
| Vaughn James J (Chief Commercial Officer) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Disposed/sold 5,249 shares
@ $0
Disposed/sold 11,281 shares
@ $0
Disposed/sold 17,739 options to buy
@ $27, valued at
$479k
Disposed/sold 5,142 options to buy
@ $27, valued at
$138.8k
Disposed/sold 18,027 options to buy
@ $27.48, valued at
$495.4k
Disposed/sold 16,900 options to buy
@ $27.48, valued at
$464.4k
Disposed/sold 13,376 options to buy
@ $33.21, valued at
$444.2k
Disposed/sold 26,331 options to buy
@ $33.21, valued at
$874.5k
Disposed/sold 9,530 options to buy
@ $72.52, valued at
$691.1k
|
|
| 11/14/2019 |
4
| Pla Frederic (COO) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Disposed/sold 18,510 shares
@ $0
Disposed/sold 13,381 shares
@ $0
Disposed/sold 77,167 options to buy
@ $31.98, valued at
$2.5M
Disposed/sold 12,625 options to buy
@ $27, valued at
$340.9k
Disposed/sold 5,142 options to buy
@ $27, valued at
$138.8k
Disposed/sold 24,864 options to buy
@ $27.48, valued at
$683.3k
Disposed/sold 17,538 options to buy
@ $27.48, valued at
$481.9k
Disposed/sold 29,544 options to buy
@ $33.21, valued at
$981.2k
Disposed/sold 37,986 options to buy
@ $33.21, valued at
$1.3M
Disposed/sold 28,570 options to buy
@ $72.52, valued at
$2.1M
|
|
| 11/14/2019 |
4
| Shak Steven (Chief Scientific Officer) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Disposed/sold 49,585 shares
@ $0
Disposed/sold 9,210 shares
@ $0
Disposed/sold 42,423 options to buy
@ $27, valued at
$1.1M
Disposed/sold 3,857 options to buy
@ $27, valued at
$104.1k
Disposed/sold 32,168 options to buy
@ $27.48, valued at
$884k
Disposed/sold 14,622 options to buy
@ $27.48, valued at
$401.8k
Disposed/sold 18,186 options to buy
@ $33.21, valued at
$604k
Disposed/sold 23,384 options to buy
@ $33.21, valued at
$776.6k
Disposed/sold 20,180 options to buy
@ $72.52, valued at
$1.5M
|
|
| 11/14/2019 |
4
| Cole G Bradley (CFO) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Disposed/sold 27,385 shares
@ $0
Disposed/sold 11,794 shares
@ $0
Disposed/sold 1,888 options to buy
@ $28.05, valued at
$53k
Disposed/sold 20,000 options to buy
@ $30.84, valued at
$616.8k
Disposed/sold 55,000 options to buy
@ $31.12, valued at
$1.7M
Disposed/sold 56,558 options to buy
@ $27, valued at
$1.5M
Disposed/sold 5,142 options to buy
@ $27, valued at
$138.8k
Disposed/sold 38,582 options to buy
@ $27.48, valued at
$1.1M
Disposed/sold 17,538 options to buy
@ $27.48, valued at
$481.9k
Disposed/sold 22,894 options to buy
@ $33.21, valued at
$760.3k
Disposed/sold 29,436 options to buy
@ $33.21, valued at
$977.6k
|
|
| 11/14/2019 |
4
| Popovits Kimberly J (President and CEO) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Disposed/sold 12,298 shares
@ $0
Disposed/sold 68,268 shares
@ $0
Disposed/sold 36,168 shares
@ $0
Disposed/sold 67,500 options to buy
@ $28.05, valued at
$1.9M
Disposed/sold 100,000 options to buy
@ $30.84, valued at
$3.1M
Disposed/sold 141,038 options to buy
@ $27, valued at
$3.8M
Disposed/sold 12,822 options to buy
@ $27, valued at
$346.2k
Disposed/sold 131,656 options to buy
@ $27.48, valued at
$3.6M
Disposed/sold 59,844 options to buy
@ $27.48, valued at
$1.6M
Disposed/sold 72,231 options to buy
@ $33.21, valued at
$2.4M
Disposed/sold 92,869 options to buy
@ $33.21, valued at
$3.1M
|
|
| 11/13/2019 |
SC 13G
| ICS OPPORTUNITIES, LTD. reports a 0% stake in GENOMIC HEALTH, INC. |
| 11/13/2019 |
SC 13D/A
| EXACT SCIENCES CORP reports a 100% stake in GENOMIC HEALTH, INC. |
| 11/13/2019 |
4
| EXACT SCIENCES CORP (10% Owner) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Bought 37,643,330 shares
@ $0 |
|
| 11/08/2019 |
8-K
| Resignation/termination of a director |
| 11/08/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/08/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/08/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/08/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/08/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/08/2019 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 11/08/2019 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 11/08/2019 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 11/07/2019 |
8-K
| Quarterly results |
| 10/30/2019 |
10-Q
| Quarterly Report for the period ended September 30, 2019 |
| 10/29/2019 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/29/2019 |
425
| Form 425 - Prospectuses and communications, business combinations: |
|
|
|